These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11395378)

  • 1. Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays.
    Luzzi V; Holtschlag V; Watson MA
    Am J Pathol; 2001 Jun; 158(6):2005-10. PubMed ID: 11395378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays.
    King C; Guo N; Frampton GM; Gerry NP; Lenburg ME; Rosenberg CL
    J Mol Diagn; 2005 Feb; 7(1):57-64. PubMed ID: 15681475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis.
    Luzzi V; Mahadevappa M; Raja R; Warrington JA; Watson MA
    J Mol Diagn; 2003 Feb; 5(1):9-14. PubMed ID: 12552074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of primary tumor cell populations using laser capture microdissection, RNA transcript amplification, and GeneChip microarrays.
    Luzzi VI; Holtschlag V; Watson MA
    Methods Mol Biol; 2005; 293():187-207. PubMed ID: 16028420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
    Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M
    Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR.
    Glöckner S; Lehmann U; Wilke N; Kleeberger W; Länger F; Kreipe H
    Pathobiology; 2000; 68(4-5):173-9. PubMed ID: 11279343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions.
    Jeffrey SS; Pollack JR
    Breast Cancer Res; 2003; 5(6):320-8. PubMed ID: 14580250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
    Hartmann K; Schlombs K; Laible M; Gürtler C; Schmidt M; Sahin U; Lehr HA
    Diagn Pathol; 2018 Oct; 13(1):83. PubMed ID: 30342538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization.
    Ohyama H; Zhang X; Kohno Y; Alevizos I; Posner M; Wong DT; Todd R
    Biotechniques; 2000 Sep; 29(3):530-6. PubMed ID: 10997267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of laser capture microdissection-generated targets for hybridization of high-density oligonucleotide arrays.
    Ohyama H; Mahadevappa M; Luukkaa H; Todd R; Warrington JA; Wong DT
    Methods Enzymol; 2002; 356():323-33. PubMed ID: 12418211
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of microinvasive breast cancer microenvironment progression.
    Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
    J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and PARP1 mRNA expression during progression from normal breast to ductal carcinoma in situ and invasive breast cancer: a laser microdissection study.
    Hybiak J; Domagala P; Domagala W
    Pol J Pathol; 2018; 69(4):347-355. PubMed ID: 30786684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.